During the past decade, Bryan Heart conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 15 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bryan Heart" #1 sponsor was "Abbott Medical Devices" with 6 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored, "Amgen" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Quark Pharmaceuticals" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bryan Heart" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "National Institute of Nursing Research (NINR)" with 2 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator and "Canadian VIGOUR Centre" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Bryan Heart" are "Heart Failure" (11 trials), "Heart Failure, Congestive" (4 trials), "Acute Kidney Injury" (3 trials), "Atrial Fibrillation" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Bryan Heart" in a lesser frequency.

Most popular intervention types in "Bryan Heart" are "Device" (21 trials), "Drug" (17 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "bococizumab (PF-04950615)" (2 trials), "6-minutes walk performance" (1 trials), "ANG-3777" (1 trials) and "Ad5FGF-4" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bryan Heart" are 42 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Bryan Heart". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Bryan Heart, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Bryan Heart, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 18 trials that are defined as “Not Applicable".